Galmed Pharmaceuticals (GPH.F) Q3 2025 Earnings

28AugConfirmed
Q4 2024
Q2 2025
Q2 2025
Q3 2025
-1.78
-1.37
-0.95
-0.54

Details

Expected EPS
-0.7105214999999999
Actual EPS
-0.5393114999999999
Surprise EPS
0.17
Surprise Percent
+24.1%

Description

Galmed Pharmaceuticals (GPH.F) has reported earnings of -0.5393114999999999 per share for Q3 2025.

0 Comments

Share your thoughts